» Articles » PMID: 22655080

Role of C-Jun N-terminal Protein Kinase 1/2 (JNK1/2) in Macrophage-mediated MMP-9 Production in Response to Moraxella Catarrhalis Lipooligosaccharide (LOS)

Overview
Journal PLoS One
Date 2012 Jun 2
PMID 22655080
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Moraxella catarrhalis is a gram negative bacterium and a leading causative agent of otitis media (OM) in children. Recent reports have provided strong evidence for the presence of high levels of matrix metalloproteinase (MMPs) in effusion fluids from children suffering with OM, however, the precise mechanisms by which MMPs are generated are currently unknown. We hypothesized that MMPs are secreted from macrophages in the presence of M. catarrhalis lipooligosaccharide (LOS). In this report, we demonstrate that in vitro stimulation of murine macrophage RAW 264.7 cells with LOS leads to secretion of MMP-9 as determined by ELISA and zymogram assays. We have also shown that inhibition of ERK1/2 and p38 kinase completely blocked LOS induced MMP-9 production. In contrast, inhibition of JNK1/2 by the specific inhibitor SP600125 actually increased the level of expression and production of MMP-9 at both mRNA and protein levels, respectively by almost five fold. This latter result was confirmed by knocking down JNK1/2 using siRNA. Similar results have been observed in murine bone marrow derived macrophages in vitro. In contrast to and in parallel with the LOS-induced increased levels of MMP-9 in the presence of SP600125, we found a corresponding dose-dependent inhibition of TIMP-1 (tissue inhibitor of matrix metalloproteinase-1) secretion. Results of subsequent in vitro studies provided evidence that when JNK1/2 was inhibited prior to stimulation with LOS, it significantly increased both the extent of macrophage cell migration and invasion compared to control cells or cells treated with LOS alone. The results of these studies contribute to an increased understanding of the underlying pathophysiology of OM with effusion in children.

Citing Articles

Vaccine targets against Moraxella catarrhalis.

Ren D, E Pichichero M Expert Opin Ther Targets. 2015; 20(1):19-33.

PMID: 26565427 PMC: 4720561. DOI: 10.1517/14728222.2015.1081686.


Molecular mechanisms of moraxella catarrhalis-induced otitis media.

Hassan F Curr Allergy Asthma Rep. 2013; 13(5):512-7.

PMID: 23934577 DOI: 10.1007/s11882-013-0374-8.


IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways.

Tseng H, Lee I, Lin C, Chi P, Cheng S, Shih R PLoS One. 2013; 8(3):e57955.

PMID: 23505448 PMC: 3591450. DOI: 10.1371/journal.pone.0057955.

References
1.
Edebrink P, Jansson P, Rahman M, Widmalm G, Holme T, Rahman M . Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res. 1994; 257(2):269-84. DOI: 10.1016/0008-6215(94)80040-5. View

2.
Schonermark M, Mester B, Kempf H, Blaser J, Tschesche H, Lenarz T . Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas. Acta Otolaryngol. 1996; 116(3):451-6. DOI: 10.3109/00016489609137872. View

3.
Granstrom G . Middle ear infections. Periodontol 2000. 2009; 49:179-93. DOI: 10.1111/j.1600-0757.2008.00281.x. View

4.
Kessenbrock K, Plaks V, Werb Z . Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010; 141(1):52-67. PMC: 2862057. DOI: 10.1016/j.cell.2010.03.015. View

5.
Lee K, Kim S, Lee Y . SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury. Exp Mol Med. 2006; 38(4):408-16. DOI: 10.1038/emm.2006.48. View